Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes by Fankam, Aimé G et al.
RESEARCH ARTICLE Open Access
Antibacterial activities of selected Cameroonian
spices and their synergistic effects with
antibiotics against multidrug-resistant phenotypes
Aimé G Fankam
1, Victor Kuete
1*, Igor K Voukeng
1, Jules R Kuiate
1 and Jean-Marie Pages
2
Abstract
Background: The emergence of multi-drug resistant (MDR) phenotypes is a major public health problem today in
the treatment of bacterial infections. The present study was designed to evaluate the antibacterial activities of the
methanol extracts of eleven Cameroonian spices on a panel of twenty nine Gram negative bacteria including MDR
strains.
Methods: The phytochemical analysis of the extracts was carried out by standard tests meanwhile the liquid
micro-broth dilution was used for all antimicrobial assays.
Results: Phytochemical analysis showed the presence of alkaloids, phenols and tannins in all plants extracts. The
results of the antibacterial assays indicated that all tested extracts exert antibacterial activities, with the minimum
inhibitory concentration (MIC) values varying from 32 to 1024 μg/ml. The extracts from Dichrostachys glomerata,
Beilschmiedia cinnamomea, Aframomum citratum, Piper capense, Echinops giganteus, Fagara xanthoxyloïdes and Olax
subscorpioïdea were the most active. In the presence of efflux pump inhibitor, PAßN, the activity of the extract
from D. glomerata significantly increased on 69.2% of the tested MDR bacteria. At MIC/5, synergistic effects were
noted with the extract of D. glomerata on 75% of the tested bacteria for chloramphenicol (CHL), tetracycline (TET)
and norfloxacin (NOR). With B. cinnamomea synergy were observed on 62.5% of the studied MDR bacteria with
CHL, cefepime (FEP), NOR and ciprofloxacin (CIP) and 75% with erythromycin (ERY).
Conclusion: The overall results provide information for the possible use of the studied extracts of the spices in the
control of bacterial infections involving MDR phenotypes.
Background
The emergence of MDR phenotypes is a major public
health problem today in the treatment of bacterial infec-
tions. The multi-drug resistance of Gram negative bacteria
is a major cause of morbidity and mortality in health care
services [1]. The activation of bacterial efflux pumps also
plays an important role in the appearance of resistance to
antibiotics [2]. The real challenge for scientists worldwide
today, is to continuously find new drugs to combat resis-
tant microorganisms, or compounds which are able to
inhibit the resistance mechanisms of pathogens, therefore
restoring the activity of antibiotics. Medicinal plants are
rich in compounds which may be potential natural drugs
and serve as alternative, less expensive and safe antimicro-
bials for the treatment of common ailments. Plant drugs
a r ew i d e l yu s e di nA f r i c af o rt h et r e a t m e n to fm a n ya i l -
ments and constitute the first health recourse for about
80% of the population [3]. A number of pharmaceutical
products in current use worldwide are derived from plants
[4]. In Cameroon, many medicinal plants including spices
are used as herbal medicines. The present work was there-
fore designed to investigate the antibacterial potential
against MDR bacteria of some of the commonly used
medicinal spices in Cameroon such as Fagara xantoxy-
loides Watern., Dichrostachys glomerata (Forsk) Chuov,
Olax subscorpioïdea Oliv., Solanum melongeua L. Var
inerme D.C Hiern, Piper capense Lin.f, Xylopia aethiopica
Dunal A. Rich., Aframomum citratum (Pereira). Schum,
Scorodophloeus zenkeri Harms., Beilschmiedia cinnamo-
mea (Stapf) Robyns & Wilczek, Echinops giganteus A. Rich
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extended to the evaluation of the potencies of the above
plant extracts to increase the activity of some antibiotics
on MDR bacteria. The role of bacterial efflux pumps in
resistance to the extracts was also studied.
Methods
Plant materials and extraction
The eleven edible spices used in this work were purchased
from Dschang local market, West Region of Cameroon in
January 2010. The collected spices materials were: the
fruits of Fagara xanthoxyloides, Dichrostachys glomerata,
Olax subscorpioïdea, Solanum melongeua, Piper capense
and Xylopia aethiopica, the bark of Aframomum citratum,
Scorodophloeus zenkeri, Beilschmiedia cinnamomea and
the roots of Echinops giganteus and Mondia whitei.T h e
plants were identified by Mr. Fulbert Tadjouteu of the
National herbarium (Yaoundé, Cameroon) where voucher
specimens were deposited under the reference numbers
(Table 1).
The air dried and powdered sample (1 kg) from each
spice was extracted with methanol (MeOH) for 48 h at
room temperature. The extract was then concentrated
under reduced pressure to give residues which constituted
the crude extracts. They were then kept at 4°C until
further use.
Preliminary phytochemical investigations
The major classes of secondary metabolites; alkaloids,
anthocyanins, anthraquinones, flavonoids, phenols, sapo-
nins, tannins, steroids and triterpenes were screened
according to the common phytochemical methods
described by Harborne [5] with some modifications.
Briefly, for alkaloids (5 mg plant extract in 10 ml metha-
nol); a portion of 2 ml extract + 1% HCl + steam, 1 ml fil-
trate + 6 drops of Mayor’s reagents/Wagner’sr e a g e n t /
Dragendroff reagent; creamish precipitate/brownish-red
precipitate/orange precipitate indicated the presence of
respective alkaloids. For tannins (5 mg plant extract in
10 ml distilled water); a portion of 2 ml + 2 ml FeCl3;
blue-black precipitate indicated the presence of tannins.
For saponins (frothing test: 0.5 ml filtrate + 5 ml distilled
water); frothing persistence indicated presence of sapo-
nins. For steroids and triterpenoids (Liebermann-Burchard
reaction: 5 mg plant extract in 10 ml chloroform, filtered);
a 2 ml filtrate + 2 ml acetic anhydride + conc. H2SO4.
Blue-green ring or pink-purple indicated the presence of
steroids or triterpenoids. For flavonoids (5 mg plant
extract in 10 ml methanol); a portion of 2 ml + conc.
HCl + magnesium; ribbon pink-tomato red color indicated
the presence of flavonoids. For anthocyanins (5 mg plant
extract in 10 ml methanol); a portion 2 ml + 1%
HCl +heating; orange color indicated the presence of
anthocyanins. For anthraquinones (5 mg plant extract in
10 ml methanol); a portion of 2 ml + 2 ml ether-chloro-
form 1:1 v/v + 4 ml NaOH 10% (w/v); red color indicated
the presence of anthraquinones. For phenols (5 mg plant
material in 10 ml methanol); a portion of 2 ml + 2 ml
FeCl3; violet-blue or greenish color indicated the presence
of phenols.
Chemicals for antimicrobial assays
Tetracycline (TET), cefepime (FEP), streptomycin (STR),
ciprofloxacin (CIP), norfloxacin (NOR), chloramphenicol
(CHL), cloxacillin (CLX), ampicillin (AMP), erythromy-
cin (ERY), kanamycin (KAN) (Sigma-Aldrich, St Quentin
Fallavier, France) were used as reference antibiotics.
p-Iodonitrotetrazolium chloride (INT) and phenylalanine
arginine b-naphthylamide (PAßN) were used as microbial
growth indicator and efflux pumps inhibitor respectively.
Bacterial strains and culture media
The studied microorganisms included reference (from
the American Type Culture Collection) and clinical
(Laboratory collection) strains of Providencia stuartii,
Pseudomonas aeruginosa, Klebsiella pneumoniae, Escheri-
chia coli, Enterobacter aerogenes and Enterobacter cloa-
cae (Table 2). They were maintained on agar slant at 4°C
and sub-cultured on a fresh appropriate agar plates 24 h
prior to any antimicrobial test. Mueller Hinton Agar was
used for the activation of bacteria. The Mueller Hinton
Broth (MHB) was used for the MIC determinations.
Bacterial susceptibility determinations
The respective MICs of samples on the studied bacteria
were determined using rapid INT colorimetric assay [6,7].
Briefly, the test samples were first dissolved in DMSO/
MHB. The solution obtained was then added to MHB,
and serially diluted two fold (in a 96-wells microplate).
One hundred microlitres (100 μl) of inoculum (1.5 × 10
6
CFU/ml) prepared in MHB was then added. The plates
were covered with a sterile plate sealer, then agitated to
mix the contents of the wells using a shaker and incubated
at 37°C for 18 h. The final concentration of DMSO was
lower than 2.5% and did not affect the microbial growth.
Wells containing MHB, 100 μl of inoculum and DMSO at
a final concentration of 2.5% served as negative control
(this internal control was systematically added). The total
volume in each well was 200 μl. Chloramphenicol was
used as reference antibiotic. The MICs of samples were
detected after 18 h incubation at 37°C, following addition
(40 μl) of 0.2 mg/ml INT and incubation at 37°C for 30
minutes. Viable bacteria reduced the yellow dye to pink.
MIC was defined as the lowest sample concentration that
prevented this change and exhibited complete inhibition
of microbial growth [8].
Samples were tested alone and then, in the presence
of PAßN at 30 μg/ml final concentration. Two of the
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mea] were also tested in association with antibiotics at
MIC/2 and MIC/5. These concentrations were selected
following a preliminary assay on one of the tested MDR
bacteria, P. aeruginosa PA124 (See Additional file 1,
Table A1). All assays were performed in triplicate and
repeated thrice. Fractional inhibitory concentration
(FIC) was calculated as the ratio of MICAntibiotic in combi-
nation/MICAntibiotic alone and the interpretation made as
follows: synergistic (<0.5), indifferent (0.5 to 4), or
antagonistic (>4) [9] (The FIC values available in Addi-
tional file 1, Tables A2 and A3).
Results
Phytochemical composition of the spice extracts
The results of the phytochemical studies (Table 3)
showed that all the tested extracts contain alkaloids,
phenols and tannins. Anthocyanins, anthraquinones,
flavonoids, saponins, sterols and triterpenes were selec-
tively present.
Antibacterial activity of the spice extracts
The results of the antibacterial activity of the extract
alone on a panel of Gram negative bacteria are summar-
ized in Table 4. It appears that the extract from
Table 1 Spices used in the present study and evidence of their activities.
Spice samples (Family) Herbarium
Voucher
number
a
Part used Bioactive (or potentially active) compounds
b and screened activity
c for
crude plant extract
Fagara xanthozyloïdes
Watern. (Rutaceae)
21793/HNC/SRF Fruits Antimicrobial activity of essential oil [S: Ec, Bc, Bs, Af, Kp, Sa, Sf [19]; Cytotoxicity
of fruits crude methanol extract [weak activity on leukemia CCRF-CEM and
CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines] [27]
Dichrostachys glomerata
(Forsk) chuov (Mimosaceae)
15220/SRF-Cam Bark, fruits Cytotoxicity of roots crude methanol extract [weak activity on leukemia CCRF-
CEM and CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines][27]
Aframomum citratum
(Pereira). Schum (Zingiberaceae)
37736/SRF-Cam Leaves, fruits Cytotoxicity of leaves crude methanol extract [weak activity on leukemia CCRF-
CEM and CEM/ADR5000 cells, and pancreatic MiaPaCa-2 cell lines] [27]
Beilschmiedia cinnamomea (Stapf)
Robyns & Wilczek (Lauraceae)
6933/SRF-Cam Roots /
Echinops giganteus
A. Rich. (Asteraceae)
23647/SRF-Cam Rhizomes Antimicrobial [lupeol sitosteryl; b-D-glucopyranoside] [28-31]; Cytotoxicity of
rhizome crude methanol extract [Significant activity with IC50 values of 6.68;
7.96 and 9.84 μg/ml respectively on leukemia CCRF-CEM cells, CEM/5000 cells
and pancreatic MiaPaCa-2 cell lines] [27]
Mondia whitei
(Hook F). Skell. (Periplocaceae)
42920/HNC Fruits Reproduction system [Roots water extract (400 mg/kg/day) for 55 days caused
testicular lesions resulting in the cessation of spermatogenesis, degenerative
changes in the somniferous tubules and epididymides in rats] [32]
Olax subscorpioidea
Oliv. (Olacaceae)
3528/SRFK Seeds Antibacterial and cytotoxic against Artemia salina [Santalbic acid] [33,34];
Cytotoxicity of leaves crude methanol extract on cancer cells [weak activity on
leukemia CCRF-CEM and pancreatic MiaPaCa-2 cell lines and significant activity
with IC50 of 10.65 μg/ml on CEM/ADR5000 cells] [27]
Solanum melongena L.Var inerme
D.C Hiern. (Solanaceae)
22615/SRFC Fruits Antimicrobial activity of methanol, dichloromethane and petrol ether extracts of
the fruits: [Q: Tm, Tr, Tt, Ca et Tb [35]
Piper capense
Lin.f (Piperaceae)
7650/SRF-Cam Fruits Insecticidal [N-isobutyl-ll-(3, 4-methylenedioxyphenyl)-2E,4 E,1 0 E-
undecatrienamide; N-pyrrolidyl-12-(3, 4-methylene-dioxyphenyl)-2E,4 E,9 E,1 1 Z-
dodecatetraenamide; N-isobutyl-13-(3, 4-methylenedioxyphenyl)-2E,4 E,1 2 E-
tridecatrienamide; N-isobutyl-2E,4 E-decadienamide; N-isobutyl-2E,4 E-
dodecadienamide] [36]; Cytotoxicity of fruit crude methanol extract [Significant
activity with IC50 values of 7.02; 6.56 and 8.92 μg/ml respectively on leukemia
CCRF-CEM cells, CEM/5000 cells and pancreatic MiaPaCa-2 cell lines] [27]
Xylopia aethiopica (Dunal) A. Rich.
(Annonaceae)
16419/SRF-Cam Bark, leaves,
roots, seeds
Antimicrobial [volatile oil of seeds] [19]; Antioxidant [volatile oil of seeds] [37];
Cytotoxicity of seeds crude methanol extract [Significant activity with IC50
values of 3.91; 7.4 and 6.86 μg/ml respectively on leukemia CCRF-CEM cells,
CEM/5000 cells and pancreatic MiaPaCa-2 cell lines] [27]
Scorodophloeus zenkeri
Harms. (Caesalpinaceae)
44803/SRF-Cam Bark Antimicrobial: [2, 4, 5, 7-Tetrathiaoctane; 2, 4, 5, 6, 8-pentathianonane; 2, 3, 4, 6,
8-pentathianonane; 2, 3, 5, 6, 8, 10-hexathiaundecane; 2, 3, 5-trithiahexane 5-
oxide; 2, 4, 5, 7-tetrathiaoctane 2-oxide; 2, 3, 5, 7-tetrathiaoctane 3, 3-dioxide; 2,
3, 5-trithiahexane 3, 3-dioxide [38]; Cytotoxicity of bark crude methanol extract
on cancer cells [weak activity on leukemia CCRF-CEM and pancreatic MiaPaCa-2
cell lines and significant activity with IC50 of 10.65 μg/ml on CEM/ADR5000
cells] [27]
a(HNC): Cameroon National Herbarium; (SRF): Société des reserves forestières; Cam: Cameroon;
b(/): Not reported
c[Screened activity: significant (S: CMI < 100 μg/ml), moderate (M: 100 < CMI ≤ 625 μg/ml), Weak (W: CMI > 625 μg/ml) Q: Qualitative activity based on the
determination of inhibition zone [11,12]. Tm: Trichophyton mentagophytes; Tr: Trichophyton rubrum; Tt: Trichophyton tonsurans Tb: Trichosporon beigelii; Ca: Candida
albicans; Ck: Candida krusei; Af: Aspergillus flavus; Bc: Bacillus cereus; Bs: Bacillus subtilis; Ec: Escherichia coli; Kp: Klebsiella pneumoniae; Sa: Staphylococcus aureus; Sf:
Streptococcus faecalis.
Fankam et al. BMC Complementary and Alternative Medicine 2011, 11:104
http://www.biomedcentral.com/1472-6882/11/104
Page 3 of 11D. glomerata w a sa b l et op r e v e n tt h eg r o w t ho fa l lt h e
twenty nine tested bacteria with MIC ≤ 1024 μg/ml. All
other samples showed selective activity; their inhibitory
activity being recorded on 28 of the 29 (96.6%) tested
bacteria for B. cinnamomea, 24/29 (82.8%) for A. citra-
tum, 19/29 (62.5%) for P. capense, 18/29 (62.1%) for E.
giganteus and F. Xanthoxyloïdes, 15/29 (51.7%) for O.
subscorpioïdea, 13/29 (44.8%) for X. aethiopica, 12/29
(41.4%) for M. whitei, 6/29 (20.7%) for S. melongena and
4/29 (13, 79%) for S. zenkeri.
MIC values below 100 μg/ml (Table 4) were recorded
with the extract of B. cinnamomea against Enterobacter
Table 2 Bacterial strains and features
Strains Features References
Escherichia coli
ATCC8739 and
ATCC10536
Reference strains
AG100 Wild-type E. coli K-12 [39]
AG100A AG100 ΔacrAB::KAN
R [39]
AG100ATET ΔacrAB mutant de AG100, avec le gène acrF sur-exprimé; TET
R [39]
AG102 ΔacrAB mutant AG100, owing acrF gene markedly over-expressed; TET
R [40]
MC4100 Wild type E. coli
W311O Wild type E. coli [41]
Enterobacter
aerogenes
ATCC13048 Reference strains
EA-CM64 CHL
R resistant variant obtained from ATCC13048 over-expressing the AcrAB pump [42]
EA3 Clinical MDR isolate; CHL
R, NOR
R, OFX
R, SPX
R, MOX
R, CFT
R, ATM
R, FEP
R [42]
EA27 Clinical MDR isolate exhibiting energy-dependent norfloxacin and
chloramphenicol efflux with KAN
R AMP
R NAL
R STR
R TET
R
[42,43]
EA289 KAN sensitive derivative of EA27 [43,44]
EA294 EA289 acrA::KAN
R [44]
EA298 EA 289 tolC::KAN
R [44]
Enterobacter
cloacae
ECCI69 Clinical isolates Laboratory collection of UNR-MD1,
University of Marseille, France
BM47 Clinical isolates Laboratory collection of UNR-MD1,
University of Marseille, France
BM67 Clinical isolates Laboratory collection of UNR-MD1,
University of Marseille, France
Klebsiella
pneumoniae
ATCC12296 Reference strains
KP55 Clinical MDR isolate, TET
R , AMP
R, ATM
R, CEF
R [45]
KP63 Clinical MDR isolate, TET
R, CHL
R, AMP
R, ATM
R [45]
K24 AcrAB-TolC Laboratory collection of UNR-MD1,
University of Marseille, France
K2 AcrAB-TolC Laboratory collection of UNR-MD1,
University of Marseille, France
Providencia stuartii
NEA16 Clinical MDR isolate, AcrAB-TolC
ATCC29914 Clinical MDR isolate, AcrAB-TolC [46]
PS2636 Clinical MDR isolate, AcrAB-TolC
PS299645 Clinical MDR isolate, AcrAB-TolC
Pseudemonas
aeruginosa
PA 01 Reference strains
PA 124 MDR clinical isolate [26]
aAMP, ATM
R, CEF
R, CFT
R, CHL
R, FEP
R, KAN
R, MOX
R, STR
R, TET
R. Resistance to ampicillin, aztreonam, cephalothin, cefadroxil, chloramphenicol, cefepime, kanamycin,
moxalactam, streptomycin, and tetracycline; MDR: Multidrug resistant.
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Page 4 of 11Table 3 Extraction yields, aspects and phytochemical composition of the plant extracts
Spice samples Extraction yield* Physical aspect Phytochemical composition
Alkaloids Anthocyanins Anthraquinones Flavonoids Phenols Saponins Tannins Sterols Triterpenes
Fagara xanthoxyloides 12.13 Oily brown + - + + + - + - -
Dichrostachys glomerata 18.29 Brown paste + + + + + + + + +
Aframomum citratum 16.32 Brown paste + - - + + + + + -
Beilschmiedia cinnamomea 5.67 Black paste + + + + + - + - +
Echinops giganteus 8.87 Oily brown + + + + + - + - +
Mondia whitei 7.33 Brown paste + + + + + + + + +
Olax subscorpioidea 12.34 Brown paste + - + + + - + - +
Solanum melongena 14.30 Black paste + + + + + + + + +
Piper capense 12.87 Brown paste + - - - + + + + +
Xylopia aethiopica 26.42 Brown paste + - - - + + + - +
Scorodophloeus zenkeri 4.67 Brown paste + - - - + + + - +
(+): Present; (-): Absent; *The yield was calculated as the ratio of the obtained methanol extract according to the initial mass of the spice powder
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1Table 4 Minimal inhibitory concentration (MIC) of the studied spice extracts and CHL on the studied bacterial species
Tested samples and MIC in μg/ml in the absence and presence of PAßN (in parenthesis)
Bacterial strains F.
xanthoxyloides
D.
glomerata
A.
citratum
B. cinnamomea E.
giganteus
M.
whitei
S.
melongena
O.
subscorpioidea
P.
capense
X.
aethiopica
S. zenkeri CHL
E. coli
ATCC8739 - (1024) 1024 (512) 1024 (256) - (256) - (-) - (1024) - (128) - (-) - (512) - (512) - (-) 4 (< 2)
ATCC10536 1024 512 (128) 1024 1024 1024 1024 - 512 256 64 256 < 2 (< 2)
AG100 256 512 (256) 1024 (1024) 1024 (1024) 1024 (1024) 1024 (-) 1024 (-) 512 (-) - (1024) 1024 (1024) - (-) 8 (< 2)
AG100A 1024 1024 (256) 1024 1024 1024 - - 1024 1024 - - < 2 (< 2)
AG100ATET - 1024 (512) 1024 512 1024 - - - 1024 1024 - 64 (< 2)
AG102 1024 512 (256) 1024 512 1024 - - 1024 1024 1024 - 32 (< 2)
MC4100 256 256(< 8) 512 256 512 1024 1024 1024 1024 1024 - 32
W3110 - (512) 256 (< 8) 512 (< 8) 1024 (< 8) 1024 (1024) 1024 (512) - 512 (512) 1024 (1024) - (-) - (-) 4 (< 2)
E. aerogenes -
ATCC13048 - 512 (512) 1024 512 - - - - - - - 8 (< 2)
CM64 - (-) 512 (512) - (1024) 1024 (1024) 1024 (1024) 1024 (-) - (-) - (-) - (-) - (-) - (-) 256 (8)
EA3 1024 1024 (1024) - 1024 - - - 1024 1024 - - - (128)
EA27 1024 512 (256) 1024 1024 1024 1024 - 512 1024 1024 - 256 (< 2)
EA289 - 1024 (1024) 1024 512 1024 - - - - - - - (64)
EA298 - 1024 (128) - 1024 - 1024 - 256 512 1024 128 64 (< 2)
EA294 256 128 512 64 256 - 1024 256 256 256 512 8
E. cloacae
ECCI69 512 (-) 1024 (1024) 1024 (1024) 1024 (512) 1024 (-) - (-) - (-) - (-) - -(1024) - (256) - (16)
BM47 1024 (1024) 1024 (256) 1024 (1024) 1024 (1024) 1024 (-) - (-) - (-) - (-) 512(64) 1024(1024) - (-) - (< 2)
BM67 1024 (1024) 1024 (128) 1024 1024 - - - - 512 1024 - 256 (16)
K. pneumoniae
ATCC11296 1024 (1024) 512 (128) 512 (512) 256 (256) 1024 (256) - (1024) - (1024) 1024 (512) 1024 (256) - (-) - (-) 4 (< 2)
KP55 1024 512 (256) 1024 512 - - - 1024 1024 - - 64 (2)
KP63 1024 512 (< 8) 256 512 512 1024 512 256 256 64 - 64 (< 2)
K24 512 512 (32) 512 256 32 1024 1024 - 1024 - - 16 (< 2)
K2 - 1024 (128) - 1024 - - - 1024 512 - - 32 (4)
P. stuartuii
NEA16 1024 512 (32) 128 256 1024 1024 1024 512 256 512 1024 32 (8)
ATCC29914 1024 1024 (512) 512 512 1024 1024 - - 1024 - - 16 (8)
PS2636 - 512 1024 1024 - - - - - - - 32
PS299645 1024 (-) 256 (256) 256 256 (512) - (-) - (-) - (512) - (-) - (-) - (-) - (-) 32 (< 2)
P. aeruginosa
PA01 - 1024 (512) 1024 1024 - - - - - 1024 - 16 (< 2)
PA124 - 512 (512) - 1024 - 1024 - - - - - 32 (< 2)
(-): MIC not detected at up to 1024 μg/ml for the les extracts and 256 μg/ml for CHL. (): values in parenthesis are MIC of substance in the presence of PAßN at 30 μg/ml. The MIC of PAßN was 64 μg/ml on E. coli,
AG100A, 512 μg/ml on ATCC11296, BM67, EA27, EA289; 1024 μg/ml on AG100ATET, ATCC13048, CM64; and > 1024 μg/ml on other bacteria. CHL: chloramphénicol
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1aerogenes EA294 (64 μg/ml), E. giganteus on Klebsiella
pneumoniae K24 (32 μg/ml) and X. aethiopica on
Escherichia coli ATCC10536 and Klebsiella pneumoniae
KP63 (64 μg/ml).
Role of efflux pumps in susceptibility of Gram negative
bacteria to the tested spice extracts
The various strains and MDR isolates were tested for their
susceptibilities to the spice extracts, and reference antibio-
tic, CHL in the presence of PAßN, a well-known efflux
pump inhibitor. The results presented in Table 4 showed
that the activity of the extract from D. glomerata signifi-
cantly increased in the presence of PAßN on 18/26
(69.2%) of the tested bacteria. The MIC values below
100 μg/ml were noted with this extract against E. coli
MC4100 and W3110 (< 8 μg/ml), K. pneumoniae KP63
and K24 (< 8 μg/ml and 32 μg/ml respectively) and
P. stuartii NAE16 (32 μg/ml). Apart from the extract of
D. glomerata, PAßN did not induce an increased activity
of other tested extract.
Effects of the association of some spice extracts with
antibiotics
To evaluate the possible synergistic effects of the extracts
with antibiotics, four of the most active samples
(F. xanthoxyloïdes, D. glomerata, B. cinnamomea and O.
subscorpioïdea) were selected. A preliminary study using
P. aeruginosa PA124, one of the MDR bacteria used in
this work, was carried out with ten antibiotics (CLX,
AMP, ERY, KAN, CHL, TET, FEP, STR, CIP and NOR) to
select the appropriate sub-inhibitory concentrations to be
used. The results (see Additional file 1, Table A1) allow
the selection of MIC/2 and MIC/5 as the sub-inhibitory
concentrations of the extracts from D. glomerata and
B. cinnamomea, which were then tested on eight MDR
bacteria, E. coli AG100, AG100TET, K. pneumoniae KP55,
E. aerogenes EA3, EA27, EA289, CM64 in addition to
P. aeruginosa PA124. The results are summarized in
Tables 5 and 6. Synergistic effects were observed with the
association between D. glomerata (Table 5, Additional file
1, Table A2) and B. cinnamomea (Table 6, Additional file
1, Table A3) and most of the antibiotics on the studied
MDR bacteria. At MIC/2, synergistic effects were noted
with the extract of D. glomerata on 25% (2/8) of the tested
bacteria for CLX and AMP, 50% (4/8) for KAN, 62.5% (5/
8) for CHL, FEP, STR, CIP, 75% (6/8) for ERY and 87.5%
(7/8) for NOR and TET. Increase in MIC values of > 8
f o l dw e r er e c o r d e da tM I C / 2w i t hC H L ,T E T ,S T R ,C I P ,
NOR (Table 5). At MIC/5, synergistic effects were noted
on 50% of the eight tested MDR bacteria in the case of
STR and CIP, 62.5% in the case of ERY and 75% in the
case of CHL, TET and NOR.
The extract of B. cinnamomea at MIC/2 (Table 6) also
induced significant increase of the activity of several
antibiotics, the synergistic effects being noted on 25% of
the tested bacteria in the case of CLX and AMP, 50% in
t h ec a s eo fK A N ,6 2 . 5 %i nt h ec a s eo fF E Pa n dS T R ,
75% in the case of CHL, TET and CIP, 87.5% in the
case of ERY and 100% for NOR. With this extract,
synergistic effects were also observed at MIC/5 on 25%
of the studied MDR bacteria in the case of CLX and
A M P ,3 7 . 5 %i nt h ec a s eo fS T Ra n dK A N ,5 0 %i nt h e
c a s eo fT E T ,6 2 . 5 %i nt h ec a s eo fC H L ,F E P ,N O Ra n d
CIP and 75% in the case of ERY.
Discussion
Phytochemical composition of the spice extracts
Phytochemical screening revealed the presence of several
classes of secondary metabolites. Though the detection of
such metabolites does not automatically predict the anti-
microbial activity of a plant extract, it has clearly been
demonstrated that several compounds belonging to the
investigated classes of metabolites showed antibacterial
activities [4,10-12].
Antibacterial activity of the spice extract
Phytochemicals are routinely classified as antimicrobials
on the basis of susceptibility tests that produce MIC in
the range of 100 to 1000 μg/ml [13]. Activity is consid-
ered to be significant if MIC values are below 100 μg/ml
for crude extract and moderate when 100 < MIC < 625
μg/ml [11]. Therefore, the activity recorded with B. cin-
namomea and E. giganteus respectively on E. aerogenes
EA294 and K. pneumoniae K24, and X. aethiopica on
E. coli ATCC10536 and K. pneumoniae KP63 can be con-
sidered significant. Alternative criteria have been
described by Fabry et al. [14], which consider extracts
having MIC values below 8000 μg/ml to have noteworthy
antimicrobial activity. Under these less stringent criteria,
and considering the fact that the spices tested are used as
food ingredients with limited toxicity, the overall activity
recorded with several extracts, most notably those of
D. glomerata, B. cinnamomea, A. citratum, P. capense,
E. giganteus, F. Xanthoxyloïdes and O. subscorpioïdea,
c o u l db ec o n s i d e r e di m p o r t a n t .B e s i d e s ,s o m eo ft h e
tested samples were more active than CHL used as refer-
ence antibiotic on some of the MDR bacteria such as
E. cloacae ECCI69 and BM47, E. aerogenes EA27 and
EA289, highlighting the importance of the results
reported herein. It can be noted that all the investigated
phytochemical classes were detected in the extracts of
D. glomerata, S. melongena and M. withei.C o n t r a r yt o
D. glomerata extract that exhibited a good spectrum of
activity, the inhibition potential of S. melongena and
M. withei was lower and seems not in correlation with
their chemical composition. This clearly confirms the
fact that the presence of secondary metabolites does not
automatically predict the antimicrobial activity of a plant
Fankam et al. BMC Complementary and Alternative Medicine 2011, 11:104
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Page 7 of 11Table 5 Minimal inhibitory concentration (MIC) in μg/ml of antibiotics in the absence and presence of the sub-inhibitory concentrations of D. glomerata
extracts against MDR bacteria.
Bacterial strains Antibiotics and MIC in absence and presence D. glomerata extracts at MIC/2 and MIC/5
Chloramphenicol Cloxacillin Ampicillin Erythromycin Kanamycin
Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5
PA124 32 32 (1)
I 16 (2)
s - - - 64 - - 64 32 (2)
s 64 (1)
I 64 16 (4)
s 64 (1)
CM64 256 256 (1)
I - - - - - - 256 - 64 128 1 1 (1)
I 1(1)
I
EA3 - 32 (> 16)
s 32 (> 16)
s - 256 256 - - - 64 32 (2)
s 64 (1)
I 32 16 (2)
s 16 (2)
s
EA27 256 32 (8)
s 64 (4)
s 256 64 (4)
s 64 (4)
s 64 64 (1)
I 64 (1)
I 32 32 (1)
I 32 (1)
I 16 16 (1)
I 16 (1)
I
EA289 - - - - - - - 256 64 256 64 (4)
s 128 (2)
s 4< 2 ( > 2 )
s 4 (1)
I
KP55 64 8 (8)
s 16 (4)
s - - - - - - 256 128 (2)
s 128 (2)
s 32 32 (1)
I 32 (1)
I
AG100ATET 64 8 (8)
s 16 (4)
s - - - - 16 32 32 32 (1)
I 16 (2)
s 32 2 (16)
s 8 (4)
s
AG100 8 < 2 (> 4)
s < 2 (> 4)
s 256 128 (2)
s 64 (4)
s 64 4 (16)
s 4 (16)
s 32 < 2 (> 16)
s 4 (8)
s <2 <2 <2
Bacterial strains Tetracycline Cefepime Streptomycin Ciprofloxacin Norfloxacin
Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5
PA124 4 < 0, 5 (> 8)
s 2 (2)
s - - - 16 16 (1)
I 16 (1)
I 16 < 0, 5 (> 8)
s 16 (1)
I 128 - -
CM64 32 4 (8)
s 8 (4)
s 256 64 (4)
s 128 (2)
s 8< 2 ( > 4 )
s 4 (2)
s 1 1 (1)
I 1 (1)
I 2 1 (2)
s 1 (2)
s
EA3 2 1 (2)
s 2 (2)
s - - - 16 8 (2)
s 8 (2)
s 64 4 (16)
s 64 (1)
I 64 32 (2)
s 64 (1)
I
EA27 16 4 (4)
s 8 (2)
s 256 128 (2)
s 128 (2)
s 8 4 (2)
s 4 (2)
s 2 2 (1)
I 2 (1)
I 16 2 (8)
s 4 (4)
s
EA289 8 1 (8)
s 2 (4)
s - 256 (> 2)
s - 64 8 (8)
s 32 (2)
s 32 16 (2)
s 16 (2)
s 64 16 (4)
s 32 (2)
s
KP55 4 2 (2)
s 2 (2)
s - 128 (> 4)
s - 8 8 (1)
I 8 (1)
I 128 4 (32)
s 32 (4)
s 128 32 (4)
s 32 (4)
s
AG100ATET 4 1 (4)
s 2 (2)
s - 32(> 16)
s - 16 2 (8)
s 16 (1)
I 64 32 (2)
s 16 (4)
s 64 8 (8)
s 16 (4)
s
AG100 < 2 < 2 (> 4)
s < 2 (> 4)
s 256 < 2 (> 128)
s < 2 (> 128)
s 256 256 (1)
I 256 (1)
I <2 <2 <2 3 2 4( 8 )
s 32 (1)
I
MIC/2: concentration of plant extract added equal to 256 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to 512 μg/ml for EA289 and AG100ATET.
MIC/5: concentration of plant extract added equal to 102.4 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to 204.8 μg/ml for EA289 and AG100ATET
(): Values in bracket are folds increase of activity. S: synergy, I: indifference; (-): > 512 μg/ml
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1Table 6 Minimal inhibitory concentration (MIC) of antibiotics in the absence and presence of the sub-inhibitory concentrations of B. cinnamomea extract (μg/
ml) against some MDR bacteria.
Bacterial strains Antibiotics and MIC in absence and presence B. cinnamomea extracts at MIC/2 and MIC/5
Chloramphenicol Cloxacillin Ampicillin Erythromycin Kanamycin
Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5
PA124 32 < 0, 5 (> 32)
s 32 (1)
s - - - - - - 64 8 (8)
s 32 (2)
s 32 32 (1) 64
CM64 256 - - - - - - - - - 64 (> 8)
s 64 (> 8)
s 1 < 0.5 (> 2)
s < 0.5 (> 2)
s
EA3 - 16 (> 32)
S 32 - 256 - - - - 64 8 (8)
s 32 (2)
s 32 16 (2)
s 16 (2)
s
EA27 256 8 (32)
s 16 (16)
s 256 < 0, 5 (> 512)
s 16(16)
s 64 64 (1)
I 64 (1)
I 32 8 (4)
s 32 (2)
s 16 < 0.5 (> 32)
s 16(1)
I
EA289 - 256 - - - - - - - 256 32 (8)
s 64 (4)
s 4 4 (1)
I 4 (1)
I
KP55 64 8 (8)
s 8 (8)
s - - - - - - 256 128 (2)
s 128 (2)
s 32 32 (1)
I 32 (1)
I
AG100ATET 64 16 (4)
s 32 (2)
s - 128 (> 4)
S 128 (> 4)
S - 8 (> 64)
S 32 (16)
S 32 32 (1)
I 32 (1)
I 32 1 (32)
s 8 (4)
s
AG100 8 < 2 (> 4)
s 4 (2)
s 256 256 (1) 256 (1) 64 < 2(> 32)
s 4 (16)
s 32 < 2 (> 16)
s 4 (8)
s <2 <2 <2
Bacterial strains Tetracycline Cefepime Streptomycin Ciprofloxacin Norfloxacin
Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5 Alone MIC/2 MIC/5
PA124 4 2 (2)
s 4 (1)
s -6 4 ( > 8 )
s - 16 16 (1) 16 (1) 16 16 (1)
I 16 (1)
I 128 64 (2)
s 64 (2)
s
CM64 32 8 (4)
s 8 (4)
s 256 32 (8)
s 32 (8)
s 8< 2 ( > 4 )
s < 2 (> 4)
s 1 1 (1)
I 1 (1)
I 2 1 (2)
s 2 (1)
I
EA3 2 1 (2)
s 2 (1)
I - - - 16 4 (4)
s 4 (4)
s 64 4 (16)
s 8(8)
s 64 16 (4)
s 32 (2)
s
EA27 16 1 (16)
s 4 (4)
s 256 16 (16)
s 64(4)
s 8 < 0.5 (> 16)
s 2 (4)
s 2 < 0.5 (> 4)
s 2 (1)
I 16 < 0.5 (> 32)
s 4 (4)
s
EA289 8 4 (2)
s 4 (2)
s - 256 (> 2)
s 256 (> 2)
s 64 16 (4)
s 64 (1)
I 32 16 (2)
s 16 (2)
s 64 32 (2)
s 32 (2)
s
KP55 4 4 (1)
I 4 (1)
I -6 4 ( > 8 )
s 128 (> 2)
s 8 8 (1)
I 8 (1)
I 128 8 (16)
s 16 (8)
s 128 16 (8)
s 32 (4)
s
AG100ATET 4 2 (2)
s 2 (2)
s - 256 (> 2)
s 64(> 4)
s 16 8 (2)
s 16 (1)
I 64 4 (16)
s 8 (8)
s 64 32 (2)
s 64 (1)
I
AG100 < 2 < 2 < 2 256 64 (4)
s 64 (4)
s 256 256 (1)
I 256 (1)
I 4< 2 ( > 2 )
s < 2 (> 2)
s 32 4 (8)
s 32 (1)
I
MIC/2: concentration of plant extract added equal to 512 μg/ml for PA124, CM64, EA3, EA27, AG100; and to 256 μg/ml for EA289, KP55 and AG100ATET
MIC/5: concentration of plant extract added equal to 204.8 μg/ml for PA124, CM64, EA3, EA27, KP55, AG100; and to102.4 μg/ml for EA289 and AG100ATET
(): Values in bracket are folds increase of activity. S: synergy, I: indifference; (-): > 512 μg/ml
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1extract though it is a good indication of its possible phar-
macological potential.
To the best of our knowledge, the antibacterial activity
of B. cinnamomea and P. capense is being reported for
the first time. Moreover, the present work reports for the
first time the activity of the tested spices on MDR bac-
teria. Nevertheless, the antimicrobial potential of some of
the plants or related genus were demonstrated on sensi-
tive strains. Banso and Adeyemo [15] reported the pre-
sence of antibacterial tannins in the genus Dichrostachys.
Chouna et al. [16] also demonstrated that Beilschmiedia
anacardioides was significantly active against Bacillus
subtilis, Micrococcus luteus and Streptococcus faecalis.
Plants of the genus Echinops such as E. ellenbeckii and
E. longisetus were found active on Staphylococcus aureus
[17] meanwhile the antibacterial activity of the essential
oils and alkaloids from F. xanthoxyloïdes was also docu-
mented [18,19]. The aqueous and ethanol extracts from
O. subscorpioïdea were found active on both bacteria and
fungi [20]. The results obtained in the present work
therefore provide additional information on the studied
plants and are in consistence with some of the previous
reports.
Role of efflux pumps in susceptibility of Gram negative
bacteria to the tested spice extracts
Tripartite efflux systems, mainly those clinically described
as AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in
P. aeruginosa, are associated with a major human health
problem as they play a central role in multidrug resistance
of pathogenic Gram negative bacteria [21-23]. PAßN has
been reported as a potent inhibitor of the RND efflux sys-
tems and is especially active on AcrAB-TolC and MexAB-
OprM [22,24,25]. To determine the role of efflux pumps
in this work, the concentration of PAßN used (30 μg/ml)
had no intrinsic effect on the bacteria as previously deter-
mined [26]. In contrast, with these conditions significant
increase of the antibacterial activity of D. glomerata extract
was noted, showing that one or more active compounds
from this plant could be substrate(s) of efflux pumps act-
ing in resistant strains of E. coli, K. pneumoniae and
P. stuartii. These data suggest that possible association
of the extract of D. glomerata a n de f f l u xp u m pi n h i b i t o r
can be envisaged to improve the fight against MDR
phenotypes.
Effects of the association of extracts from D. glomerata
and B. cinnamomea with antibiotics
The association of natural products such as plant extracts
and antibiotics constitutes an alternative in the fight
against MDR bacteria. Significant synergistic effects were
noted with both D. glomerata and B. cinnamomea
extracts when they were associated with several antibio-
tics. Such effects might be due either to the action of the
active compounds or possible inhibition of the efflux
pumps by other compounds of the extracts. The lowest
synergistic effects were observed with b-lactamines (CLX
and AMP), obviously due to the fact their target are loca-
lized in the bacterial cell coat. However, the synergistic
effects observed indicate that active compounds of the
extract could also present different mode(s) of action
from those of the studied antibiotics.
Conclusion
The overall results of the present work provide baseline
information for the possible use of the studied spice
extracts in the treatment of bacterial infections involving
MDR phenotypes. In addition to these antibacterial
activities, the data reported herein indicated that possi-
ble combinations of the extract of D. glomerata with an
efflux pump inhibitor, and also the association of extract
of this plant as well as that from B. cinnamomea with
several antibiotics could be used in the control of bac-
terial infections involving MDR phenotypes.
Additional material
Additional file 1: Table S1. Activities of antibiotics in combination with
the sub-inhibitory concentrations of some plants extracts on Pseudomonas
aeruginosa PA124. Table S 2. Fractional Inhibitory Concentrations (FIC) of
the association between antibiotics and extract of D. glomerata at MIC/2
and MIC/5 (μg/ml) against MDR bacteria. Table S 3. Fractional Inhibitory
Concentrations (FIC) of association between antibiotics and extract of
B. cinnamomea at MIC/2 and MIC/5 (μg/ml).
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